Примери за използване на Given marketing authorisation на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Be given marketing authorisation.
Mycophenolate mofetil Teva be given marketing authorisation.
The CVMP concluded that the benefits of BTVPUR AlSap 2-4 exceed the risks for active immunisation of sheep to prevent infection, viraemia and clinical signs caused by the bluetongue virus serotypes 2 and 4, andrecommended that BTVPUR AlSap 2-4 be given marketing authorisation.
They recommended that Nonafact be given marketing authorisation.
The CVMP concluded that the benefits of BTVPUR AlSap 2-4 exceed the risks for active immunisation of sheep to prevent infection, viraemia and clinical signs caused by the bluetongue virus serotypes 2 and 4, andrecommended that BTVPUR AlSap 2-4 be given marketing authorisation.
Хората също превеждат
They recommended that Inovelon be given marketing authorisation.
The Committee therefore recommended that Cancidas be given marketing authorisation.
They recommended that Prialt be given marketing authorisation.
The Committee recommended that Riluzole Zentiva be given marketing authorisation.
The committe recommended that OPTISON be given marketing authorisation.
The Committee recommended that ReFacto AF be given marketing authorisation.
The Committee recommended that Imprida HCT be given marketing authorisation.
The Committee recommended that Twinrix Adult be given marketing authorisation.
The Committee recommended that Infanrix Hexa be given marketing authorisation.
The Committee recommended that Efavirenz Teva be given marketing authorisation.
The Committee recommended that KOGENATE Bayer be given marketing authorisation.
The Committee recommended that Tritanrix HepB be given marketing authorisation.
The Committee recommended that Tadalafil Lilly be given marketing authorisation.
The Committee recommended that Topotecan Eagle be given marketing authorisation.
The Committee therefore recommended that Cancidas be given marketing authorisation.
The Committee recommended that Repaglinide Krka be given marketing authorisation.
The Committee recommended that Olanzapine Apotex be given marketing authorisation.
The Committee recommended that Levetiracetam Sun be given marketing authorisation.
The Committee recommended that Olazax Disperzi be given marketing authorisation.
The Committee recommended that Clopidogrel HCS be given marketing authorisation.
The Committee recommended that Capecitabine Medac be given marketing authorisation.
The Committee recommended that Irbesartan Winthrop be given marketing authorisation.
The Committee recommended that Thalidomide Celgene be given marketing authorisation.
The Committee recommended that Leflunomide medac be given marketing authorisation.
The Committee recommended that Rivastigmine Actavis be given marketing authorisation.